Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

The benefits of GLP1 receptors in cardiovascular diseases
L. Pojskic, Denis Mršić, Amra Macić-Džanković
Frontiers in Clinical Diabetes and Healthcare (2023) Vol. 4
Open Access | Times Cited: 43
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data
Patrick Bidulka, David G. Lugo‐Palacios, Orlagh Carroll, et al.
BMJ (2024), pp. e077097-e077097
Open Access | Times Cited: 13
Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management
Kamlesh Khunti, Francesco Zaccardi, Aslam Amod, et al.
Diabetologia (2024)
Open Access | Times Cited: 8
Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events
Edoardo Mannucci, Marco Gallo, Andrea Giaccari, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 444-453
Closed Access | Times Cited: 27
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies
André Scheen
Diabetes & Metabolism (2023) Vol. 49, Iss. 5, pp. 101474-101474
Closed Access | Times Cited: 11
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
Rozalina G. McCoy, Jeph Herrin, Kavya Swarna, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 4, pp. 431-440
Open Access | Times Cited: 3
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022
Domingo Orozco‐Beltrán, Carlos Brotons Cuixart, José R. Banegas, et al.
Atención Primaria (2022) Vol. 54, pp. 102444-102444
Open Access | Times Cited: 12
Molecular Mechanisms of Obesity-Induced Development of Insulin Resistance and Promotion of Amyloid-β Accumulation: Dietary Therapy Using Weak Organic Acids via Improvement of Lowered Interstitial Fluid pH
Yoshinori Marunaka
Biomolecules (2023) Vol. 13, Iss. 5, pp. 779-779
Open Access | Times Cited: 4
Adherence to newer second‐line oral antidiabetic drugs among people with type 2 diabetes—A systematic review
Nynne Sophie Holdt‐Caspersen, Claus Dethlefsen, Peter Vestergaard, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
A comprehensive meta-analysis on the association of SGLT2is and GLP-1RAs with vascular diseases, digestive diseases and fractures
Dehua Wang, Yu-Xia Mo, Xiang Tan, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 9, pp. 1097-1105
Closed Access | Times Cited: 1
Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative Review
María Esther Rubio-Ruíz, Juan Carlos Plata-Corona, Elizabeth Soria‐Castro, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1488-1488
Open Access | Times Cited: 1
Sex-specific Cardiovascular Risk Factors and Treatment in Females with T2DM and CVD: Developments and Knowledge Gaps
Erin S. LeBlanc, Neon Brooks, Melinda Davies, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2167-e2177
Open Access | Times Cited: 1
Recomendaciones preventivas vasculares. Actualización PAPPS 2024
Domingo Orozco‐Beltrán, Carlos Brotons-Cuixart, José R. Banegas, et al.
Atención Primaria (2024) Vol. 56, pp. 103123-103123
Open Access | Times Cited: 1
The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease
Chara Tsiampali, Paraskevi Papaioannidou, A. Goulas, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1063-1072
Closed Access | Times Cited: 3
Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020
Joshua A. Jacobs, Alexander R. Zheutlin, Catherine G. Derington, et al.
American Journal of Preventive Cardiology (2023) Vol. 17, pp. 100624-100624
Open Access | Times Cited: 3
Exploring Anti-Type 2 Diabetes Mellitus Mechanism of Gegen Qinlian Decoction by Network Pharmacology and Experimental Validation
Bao Weiping, Hongping Sun, Xiang Wu, et al.
Disease Markers (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 4
Cost-Effectiveness of Glucose-Lowering Therapies as Add-on to Standard Care for People With Type 2 Diabetes in Malaysia
Ruth Sim, Chun Wie Chong, Navin Kumar Loganadan, et al.
Value in Health Regional Issues (2023) Vol. 38, pp. 9-17
Closed Access | Times Cited: 2
Leaf extracts of Euclea natalensis A.D.C ameliorate biochemical abnormalities in high-fat-low streptozotocin-induced diabetic rats through modulation of the AMPK-GLUT4 pathway
Keagile Bati, Phazha Bushe Baeti, Goabaone Gaobotse, et al.
Egyptian Journal of Basic and Applied Sciences (2024) Vol. 11, Iss. 1, pp. 232-252
Open Access
Hypoglycemic agents and bone health; an umbrella systematic review of the clinical trials’ meta-analysis studies
Pouria Khashayar, Farid Farahani Rad, Ozra Tabatabaei‐Malazy, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access
Ethnic disparities in cardiovascular and renal responses to canagliflozin between Asian and White patients with type 2 diabetes mellitus: A post hoc analysis of the CANVAS Program
Xi Chen, Xingyun Hou, Junling Gao, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 3, pp. 878-890
Closed Access | Times Cited: 1
How do network meta-analyses address intransitivity when assessing certainty of evidence: a systematic survey
Ying Wang, Ruyu Xia, Tina Poklepović Peričić, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e075212-e075212
Open Access | Times Cited: 1
Factors associated with DPP4i or SGLT2i utilisation: a retrospective cohort study among people with type 2 diabetes mellitus
Ruth Sim, Chun Wie Chong, Navin Kumar Loganadan, et al.
Journal of Pharmacy Practice and Research (2024)
Open Access
Type 2 Diabetes mellitus treatment intensification and deintensification in primary care: a retrospective cohort study
Jay An Wong, Isabel Young, Ruth Sim, et al.
Journal of Pharmacy Practice and Research (2022) Vol. 52, Iss. 4, pp. 311-317
Open Access | Times Cited: 2
Right Ventricular Dysfunction and Exercise Impairment in Patients with Heart Failure, Insulin Resistance, and Diabetes Mellitus: Insights from the T.O.S.CA. Registry (Cardiovascular Diabetology 2022)
Giuseppe Lisco, Domenico Triggiani
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 23, Iss. 9, pp. 1240-1244
Closed Access
Page 1

Scroll to top